Johnson & Johnson Gets FDA Warning on Marketing of Products
August 24, 2010
The Associated Press reports, Johnson & Johnson has been warned by the Food and Drug Administration that it''s breaking the law with its marketing of two products. A division of Johnson & Johnson that makes joint replacements received the letter from the FDA saying the company is marketing its Corail Hip System for two unapproved uses. The FDA says Johnson & Johnson''s DePuy Orthopaedics is selling one product that was never approved for sale and is selling another product for uses that have not been specifically approved. The agency says it never approved the TruMatch Personalized Solution System, software that creates a detailed view of a patient''s knee. The FDA has told the company to stop selling the hip system for unapproved uses and to provide information needed to review the software system.